Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
109.24
(
1.02%
)
Bitcoin
68,686.61
(
1.25%
)
News Focus
News Focus
Post# of 257269
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122806
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: ghmm post# 203173

Friday, 08/05/2016 10:17:42 AM

Friday, August 05, 2016 10:17:42 AM

Post# of 257269

Couldn't the case be made that BMY would be more likely to do IO combo deals that could be synergistic?

BMY was strongly committed to Opdivo-based combination regimens in first-line NSCLC, and they continue to be strongly committed. That's why I said that the CHECKPOINT-026 setback is essentially a timing issue for the development of such regimens.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today